Literature DB >> 890240

Radiotherapy pilot trials with sensitizers of hypoxic cells: metronidazole in supratentorial glioblastomas.

R C Urtasun, J D Miller, V Frunchak, D Koziol, P R Band, J D Chapman, M L Feldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 890240     DOI： 10.1259/0007-1285-50-596-602

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  4 in total

Review 1.  Cerebral astrocytomata--trends in radiotherapy and chemotherapy: a review.

Authors:  A Jones
Journal:  J R Soc Med       Date:  1978-09       Impact factor: 5.344

2.  Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy.

Authors:  D Bahnemann; H Basaga; J R Dunlop; A J Searle; R L Willson
Journal:  Br J Cancer Suppl       Date:  1978-06

3.  Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy.

Authors:  Lei Hua; Zhen Wang; Liang Zhao; Honglin Mao; Guanghui Wang; Kairuo Zhang; Xuejiao Liu; Dongmei Wu; Yuanlin Zheng; Jun Lu; Rutong Yu; Hongmei Liu
Journal:  Theranostics       Date:  2018-10-06       Impact factor: 11.556

4.  In vivo assessment of basic 2-nitroimidazole radiosensitizers.

Authors:  M V Williams; J Denekamp; A I Minchinton; M R Stratford
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.